Abstract:BACKGROUND:Climate change is likely to further worsen ozone pollution in already heavily polluted areas, leading to increased ozone-related health burdens. However, little evidence exists in China, the world's largest greenhouse gas emitter and most populated country. As China is embracing an aging population with changing population size and falling age-standardized mortality rates, the potential impact of population change on ozone-related health burdens is unclear. Moreover, little is known about the seasonal variation of ozone-related health burdens under climate change. We aimed to assess near-term (mid-21st century) future annual and seasonal excess mortality from short-term exposure to ambient ozone in 104 Chinese cities under 2 climate and emission change scenarios and 6 population change scenarios.METHODS AND FINDINGS:We collected historical ambient ozone observations, population change projections, and baseline mortality rates in 104 cities across China during April 27, 2013, to October 31, 2015 (2013-2015), which included approximately 13% of the total population of mainland China. Using historical ozone monitoring data, we performed bias correction and spatially downscaled future ozone projections at a coarse spatial resolution (2.0° × 2.5°) for the period April 27, 2053, to October 31, 2055 (2053-2055), from a global chemistry-climate model to a fine spatial resolution (0.25° × 0.25°) under 2 Intergovernmental Panel on Climate Change Representative Concentration Pathways (RCPs): RCP4.5, a moderate global warming and emission scenario where global warming is between 1.5°C and 2.0°C, and RCP8.5, a high global warming and emission scenario where global warming exceeds 2.0°C. We then estimated the future annual and seasonal ozone-related acute excess mortality attributable to both climate and population changes using cause-specific, age-group-specific, and season-specific concentration-response functions (CRFs). We used Monte Carlo simulations to obtain empirical confidence intervals (eCIs), quantifying the uncertainty in CRFs and the variability across ensemble members (i.e., 3 predictions of future climate and air quality from slightly different starting conditions) of the global model. Estimates of future changes in annual ozone-related mortality are sensitive to the choice of global warming and emission scenario, decreasing under RCP4.5 (-24.0%) due to declining ozone precursor emissions but increasing under RCP8.5 (10.7%) due to warming climate in 2053-2055 relative to 2013-2015. Higher ambient ozone occurs under the high global warming and emission scenario (RCP8.5), leading to an excess 1,476 (95% eCI: 898 to 2,977) non-accidental deaths per year in 2053-2055 relative to 2013-2015. Future ozone-related acute excess mortality from cardiovascular diseases was 5-8 times greater than that from respiratory diseases. Ozone concentrations increase by 15.1 parts per billion (10-9) in colder months (November to April), contributing to a net yearly increase of 22.3% (95% eCI: 7.7% to 35.4%) in ozone-related mortality under RCP8.5. An aging population, with the proportion of the population aged 65 years and above increased from 8% in 2010 to 24%-33% in 2050, will substantially amplify future ozone-related mortality, leading to a net increase of 23,838 to 78,560 deaths (110% to 363%). Our analysis was mainly limited by using a single global chemistry-climate model and the statistical downscaling approach to project ozone changes under climate change.CONCLUSIONS:Our analysis shows increased future ozone-related acute excess mortality under the high global warming and emission scenario RCP8.5 for an aging population in China. Comparison with the lower global warming and emission scenario RCP4.5 suggests that climate change mitigation measures are needed to prevent a rising health burden from exposure to ambient ozone pollution in China.

Applicability of evaluation metrics/schemes for human health burden attributable to regional ozone pollution: A case study in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), South China

An Assessment of the Potential Health Benefits of Realizing the Goals for PM 10 in the Updated Chinese Ambient Air Quality Standard

Changes of PM2.5 and O3 and their impact on human health in the Guangdong-Hong Kong-Macao Greater Bay Area

Spatial and Temporal Trends in the Mortality Burden of Ozone Pollution in China: 2005-2017

Mortality Weighting-Based Method for Aggregate Urban Air Risk Assessment

Short-term effects of multiple ozone metrics on daily mortality in a megacity of China

Modeling assessment of air pollution control measures and COVID-19 pandemic on air quality improvements over Greater Bay Area of China

Alternative ozone metrics and daily mortality in Suzhou: the China Air Pollution and Health Effects Study (CAPES).

Analysis of the Spatial and Temporal Patterns of Ground-Level Ozone Concentrations in the Guangdong–Hong Kong–Macao Greater Bay Area and the Contribution of Influencing Factors

Health impacts of long-term ozone exposure in China over 2013–2017

Improved morbidity-based air quality health index development using Bayesian multi-pollutant weighted model

Impacts of Absorbing Aerosols and PM10 on Ozone Changes in the Guangdong, Hong Kong, Macao and Greater Bay Area, China

Mapping ozone source-receptor relationship and apportioning the health impact in the Pearl River Delta region using adjoint sensitivity analysis

Prediction of daily PM 2.5 and ozone based on high-density weather stations in China: Nonlinear effects of meteorology, human and ecosystem health risks

A Hybrid Model Approach for Estimating Health Burden from NO2 in Megacities in China: a Case Study in Guangzhou

Future Ozone-Related Acute Excess Mortality under Climate and Population Change Scenarios in China: A Modeling Study.

Health impacts under different ozone mitigation pathways in Beijing-Tianjin-Hebei and its surroundings

Short-Term Exposure to Fine Particulate Matter and Ozone: Source Impacts and Attributable Mortalities

Effects of using different exposure data to estimate changes in premature mortality attributable to PM2.5 and O3 in China

Health Benefit of Air Quality Improvement in Guangzhou, China: Results from a Long Time-Series Analysis (2006–2016)

Mortality burden due to long-term exposure to ambient PM 2.5 above the new WHO air quality guideline based on 296 cities in China